400-6699-1171000

分析测试百科网 认证会员,请放心拨打!

首页> 产品展示> 化合物 LOX-IN-3 dihydrochloride monohydrate T61479
普通会员

诚信认证:

工商注册信息已核实!

快速导航
品牌
其他生物化学试剂

化合物 LOX-IN-3 dihydrochloride monohydrate T61479

英文名称:LOX-IN-3 dihydrochloride monohydrate
品牌 厂商性质 产地 货期
TargetMol 生产商 美国 现货

性能特点

生化试剂,可用于动物细胞实验

在线咨询 询底价
AI问答
配套的仪器设备? 可以搭配的相关耗材试剂?
产品参数
规格 CAS号 价格 操作
100 mg 2414974-55-1 ¥24,625.00 询底价
25 mg 2414974-55-1 ¥14,900.00 询底价
50 mg 2414974-55-1 ¥19,420.00 询底价
产品介绍

Product Introduction
Bioactivity


英文名: LOX-IN-3 dihydrochloride monohydrate

描述: LOX-IN-3 dihydrochloride monohydrate (Compound 33) is a lysyl oxidase (LOX) inhibitor with oral activity. It is specifically designed for research purposes in the areas of fibrosis, cancer, and angiogenesis [1].

体外活性: LOX-IN-3 dihydrochloride monohydrate (Compound 33) inhibits the bovine LOX and human LOXL2 activities with IC 50 values of <10 μM and <1 μM, respectively [1]. LOX-IN-3 dihydrochloride monohydrate exhibits sustained inhibition of LOXL1 and LOXL2 [1]. LOX-IN-3 dihydrochloride monohydrate is less active against SSAO/VAP-1 and MAO-B activities [1].

体内活性: LOX-IN-3 dihydrochloride monohydrate (Compound 33) (30 mg/kg; orally; once) inhibits lysyl oxidase activity in rats [1]. LOX-IN-3 dihydrochloride monohydrate (10 mg/kg; orally; daily for 14 days) reduces kidney fibrosis in unilateral ureteric obstruction (UUO) mice model [1]. LOX-IN-3 dihydrochloride monohydrate (15 mg/kg; orally; daily for 21 days) reduces lung fibrosis in mice [1]. Animal Model: Male Wistar rats [1] Dosage: 30 mg/kg Administration: Oral administration, single dose Result: Completely abolished lysyl oxidase activity. Plasma concentrations of tested compound are far below the IC 50 after 8 hours, the half-life of recovery is between 2-3 days (ear) and 24 hours (aorta). Animal Model: Unilateral ureteric obstruction (UUO) model of acute kidney fibrosis in mice [1] Dosage: 10 mg/kg Administration: Oral gavage, daily for 14 days Result: Increased kidney weight and thickness and reduced the area of fibrosis. Animal Model: C57Bl/6 mice, Bleomycin-induced lung fibrosis model Dosage: 15 mg/kg Administration: Oral gavage, daily for 21 days Result: Significantly reduced the Ashcroft score and the lung weight.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

化合物 LOX-IN-3 dihydrochloride monohydrate T61479信息由TargetMol中国为您提供,如您想了解更多关于化合物 LOX-IN-3 dihydrochloride monohydrate T61479报价、型号、参数等信息,欢迎来电或留言咨询。

注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途

店铺推荐
  • 品牌:TargetMol
    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    询价
  • 品牌:TargetMol
    Cell Counting Kit-8 (CCK-8) C0005

    Cell Counting Kit-8 (CCK-8) C0005

    询价
  • 品牌:TargetMol
    SYBR Green qPCR Master Mix (No ROX) C0006

    SYBR Green qPCR Master Mix (No ROX) C0006

    询价